Showing 1 to 12 of 19 results
Brain Cancer Patient Aims to Break Marathon Fundraising Record
Iain Ward, a 36-year-old content creator with terminal brain cancer, is aiming to break the world record for most money raised by a marathon runner, currently £2.3 million, during the New York City Marathon in November.
Brain Cancer Patient Aims to Break Marathon Fundraising Record
Iain Ward, a 36-year-old content creator with terminal brain cancer, is aiming to break the world record for most money raised by a marathon runner, currently £2.3 million, during the New York City Marathon in November.
Progress
36% Bias Score
Glioblastoma Patient Shows No Signs of Cancer After Immunotherapy Treatment
A 43-year-old man, Ben Trotman, diagnosed with glioblastoma in October 2022, is cancer-free following an experimental immunotherapy treatment at University College London Hospital, defying the typical 12-18 month survival rate for this aggressive brain cancer.
Glioblastoma Patient Shows No Signs of Cancer After Immunotherapy Treatment
A 43-year-old man, Ben Trotman, diagnosed with glioblastoma in October 2022, is cancer-free following an experimental immunotherapy treatment at University College London Hospital, defying the typical 12-18 month survival rate for this aggressive brain cancer.
Progress
48% Bias Score
Swimmer Diagnosed with Brain Cancer Advocates for Increased Research Funding
22-year-old Scottish swimmer Archie Goodburn was diagnosed with inoperable brain cancer, yet continues his athletic career while advocating for increased research funding into brain cancer, a disease that receives only 1% of national funding.
Swimmer Diagnosed with Brain Cancer Advocates for Increased Research Funding
22-year-old Scottish swimmer Archie Goodburn was diagnosed with inoperable brain cancer, yet continues his athletic career while advocating for increased research funding into brain cancer, a disease that receives only 1% of national funding.
Progress
24% Bias Score
Top Cancer Researcher Awaits Critical MRI Results Amidst Stage Four Brain Cancer Return
Professor Richard Scolyer, a leading cancer researcher and 2024 Australian of the Year, awaits crucial MRI results following the return of his stage four brain cancer, highlighting the unpredictable nature of glioblastoma and the need for improved treatments.
Top Cancer Researcher Awaits Critical MRI Results Amidst Stage Four Brain Cancer Return
Professor Richard Scolyer, a leading cancer researcher and 2024 Australian of the Year, awaits crucial MRI results following the return of his stage four brain cancer, highlighting the unpredictable nature of glioblastoma and the need for improved treatments.
Progress
32% Bias Score
Oncolytic Virotherapy Shows Promise in Treating Recurrent Glioblastoma
Oncolytic viruses are demonstrating effectiveness in treating aggressive brain cancers like glioblastoma, with a Biotherapy International patient achieving remission after failing conventional treatments; this targeted approach, using the Omaya reservoir for precise drug delivery, offers improved ou...
Oncolytic Virotherapy Shows Promise in Treating Recurrent Glioblastoma
Oncolytic viruses are demonstrating effectiveness in treating aggressive brain cancers like glioblastoma, with a Biotherapy International patient achieving remission after failing conventional treatments; this targeted approach, using the Omaya reservoir for precise drug delivery, offers improved ou...
Progress
68% Bias Score
Brain Tumor Symptoms and Location: A Critical Analysis
Brain tumors are a significant cause of death in Britain, claiming 5,300 lives annually. Symptoms vary depending on tumor location, including headaches, vomiting, vision problems, seizures, and cognitive changes. Early diagnosis improves treatment outcomes.
Brain Tumor Symptoms and Location: A Critical Analysis
Brain tumors are a significant cause of death in Britain, claiming 5,300 lives annually. Symptoms vary depending on tumor location, including headaches, vomiting, vision problems, seizures, and cognitive changes. Early diagnosis improves treatment outcomes.
Progress
40% Bias Score
IDH-mutant Glioma: \$3.5 Billion Annual Economic Burden in Australia
Alex James, a 47-year-old Australian father, was diagnosed with IDH-mutant glioma in May 2023; this slow-growing but incurable brain cancer impacts over 3200 Australians, resulting in a \$3.5 billion annual economic burden projected to reach \$4.7 billion by 2050.
IDH-mutant Glioma: \$3.5 Billion Annual Economic Burden in Australia
Alex James, a 47-year-old Australian father, was diagnosed with IDH-mutant glioma in May 2023; this slow-growing but incurable brain cancer impacts over 3200 Australians, resulting in a \$3.5 billion annual economic burden projected to reach \$4.7 billion by 2050.
Progress
36% Bias Score
Australian Woman with Terminal Brain Cancer Shares Harrowing Ordeal
Anna Tarrant, a 41-year-old Sydney woman, has been diagnosed with terminal brain cancer after a 15-year battle, and shared her experience online, receiving immense community support while highlighting the limited treatment options and high mortality rate of brain cancer in Australia.
Australian Woman with Terminal Brain Cancer Shares Harrowing Ordeal
Anna Tarrant, a 41-year-old Sydney woman, has been diagnosed with terminal brain cancer after a 15-year battle, and shared her experience online, receiving immense community support while highlighting the limited treatment options and high mortality rate of brain cancer in Australia.
Progress
44% Bias Score
Misdiagnosis of Glioblastoma Leads to Terminal Diagnosis
A 61-year-old British woman, Fiona Charles, was misdiagnosed with a mini-stroke instead of glioblastoma, a lethal brain cancer, leading to a terminal diagnosis with only a year to live; her son is fundraising for brain tumor research due to the low research funding.
Misdiagnosis of Glioblastoma Leads to Terminal Diagnosis
A 61-year-old British woman, Fiona Charles, was misdiagnosed with a mini-stroke instead of glioblastoma, a lethal brain cancer, leading to a terminal diagnosis with only a year to live; her son is fundraising for brain tumor research due to the low research funding.
Progress
28% Bias Score
Michael Bolton Diagnosed with Glioblastoma, Focuses on Family Amidst Treatment
Singer Michael Bolton, 72, revealed his glioblastoma diagnosis in December 2023, undergoing two brain surgeries, radiation, and chemotherapy; he's now focused on family and cherishing time with his children.
Michael Bolton Diagnosed with Glioblastoma, Focuses on Family Amidst Treatment
Singer Michael Bolton, 72, revealed his glioblastoma diagnosis in December 2023, undergoing two brain surgeries, radiation, and chemotherapy; he's now focused on family and cherishing time with his children.
Progress
24% Bias Score
Brain Tumor Regrowth Leaves Former Australian of the Year with Months to Live
Former Australian of the Year Professor Richard Scolyer's aggressive brain tumor has regrown after multiple surgeries and experimental treatment, leaving him with a prognosis of months to live, despite exceeding typical survival rates by nine months; his case informs a world-first clinical trial for...
Brain Tumor Regrowth Leaves Former Australian of the Year with Months to Live
Former Australian of the Year Professor Richard Scolyer's aggressive brain tumor has regrown after multiple surgeries and experimental treatment, leaving him with a prognosis of months to live, despite exceeding typical survival rates by nine months; his case informs a world-first clinical trial for...
Progress
20% Bias Score
Brain Cancer Recurrence Prompts Clinical Trial
Professor Richard Scolyer, a 58-year-old Australian of the Year, faces potential recurrence of his aggressive brain cancer after a recent scan; surgery is scheduled for Monday to assess and potentially remove the tumor, though his prognosis remains 3-6 months, following an experimental treatment tha...
Brain Cancer Recurrence Prompts Clinical Trial
Professor Richard Scolyer, a 58-year-old Australian of the Year, faces potential recurrence of his aggressive brain cancer after a recent scan; surgery is scheduled for Monday to assess and potentially remove the tumor, though his prognosis remains 3-6 months, following an experimental treatment tha...
Progress
24% Bias Score
Showing 1 to 12 of 19 results